Mission Statement
“To serve our community by conducting clinical trials to facilitate the advancement of medicine and to assist in bringing new healthcare solutions to the community, while ensuring safety, quality, integrity and upholding the highest ethical standards in compliance with CFR/ICH Guidelines and Good Clinical Practice.”
Company Summary
Founded in 2006, MOORE Clinical Research, Inc. is a privately owned and operated clinical trial site, specializing and experienced in conducting multi-specialty Phase II-IV clinical trials. We have 3 site locations across the Tampa Bay area, each covering a large and diverse patient base.
Our staff comes with over 100 years of research experience collectively and has consistently demonstrated a record of quality, integrity and reliability. Our demonstrated track record since our inception in 2006, puts MOORE Clinical Research at the forefront when it comes to integrity and accuracy in clinical research.
Services & Capabilities
- Multi-specialty Phase II – IV Clinical Trials
- More than 500 clinical trials completed collectively
- Database of 16,000 searchable patients
- Consistent recruitment rate of 94%
- Consistent retention rates of over 90%
- 1-3 day turnaround for EDC entry & query resolution
- 3 newly expanded and updated clinics located in the Tampa Bay Metro area
- Access to Tampa Bay population of over 3 million
- Virtual trial and remote monitoring capabilities
- CTMS, e-Regulatory & e-Source systems in use for all studies
- Rescue site experience and capabilities
- Full time, bilingual clinical and recruitment teams
- GCP, CPR, ACLS and IATA trained staff
- PPM-CLIA licensure
- Experience with most EDC, IWRS/IVRS systems
- Private monitoring space with WiFi access
- Secure, climate controlled ambient and refrigerated drug storage with digital WiFi temperature monitoring, excursion notification and back up generator
- Centrifuges & minus 20 freezers for clinical laboratory specimen collection & handling
- Safety equipment includes crash cart, emergency meds, oxygen and defibrillators
CAPABILITIES
- Acne Vulgaris (experience with >100 trials)
- Actinic Keratosis
- ADHD
- Allergies & Asthma
- Alzheimer’s Disease
- Antidepressants
- Atopic Dermatitis
- Cardiology
- Carpel Tunnel
- Decongestants
- Dementia
- Derm Patch Adhesion
- Dermatology
- Device
- Diabetes I & II
- Diuretics
- Eplilepsy
- Herpes Labialis
- Herpes Zoster
- HPA Axis Studies
- Hyperhidrosis
- Hypertension
- Hyperlipidemia
- Immunology
- Influenza & Common Cold
- Internal Medicine
- Low Back & Neck Pain
- Male & Female Hormones
- Migraines
- Molluscum
- Onychomycosis
- Osteoarthritis, Joint Pain
- Otitis Externa
- Parkinson’s Disease
- Peripheral Neuropathy
- Pharmacokinetic Safety Labs
- Plaque Psoriasis
- Pruritis
- Restless Leg Syndrome
- Rosacea
- Scalp Psoriasis
- Skin Blanching, Irritation & Sensitization (HRIPT)
- Syringe, Needle & Injection Devices
- Tinea Pedis
- Vaccine
- Vitiligo
- Xerosis
Clinical Investigators & Certified Coordinators
- Scott Miller, MD – Board Certified Internal Medicine and Cardiovascular Disease,
Academy of Physicians in Clinical Research – 25+ years of clinical experience.
- Julian Melamed, MD – Board Certified Internal Medicine and Allergy and Clinical
Immunology, Academy of Physicians in Clinical Research – 35+ years of clinical experience
- George Monlux, MD – Board Certified Family Practice Medicine,
Academy of Physicians in Clinical Research – 25+ years of clinical experience
- Stanley Katz, MD – Board Certified Dermatology,
35+ years of clinical experience - Katherine Bencze, MD – Board Certified Neurology,
30+ years of clinical experience - Jennifer Ksaibati, ARNP, CCRP, Clinical Investigator
- Elizabeth Juneja, RN, CCRP, Director of Clinical Operations
- Theresa Lopez, CCMA, CCRP, Senior Clinical Research Coordinator
- Judy Keene, CCRP, Senior Clinical Research Coordinator
- Richard Corona, CCRP, Clinical Research Coordinator
Clinical Trial Recruitment
Each study begins with a specialized process by our recruitment team to identify and match potential patients, from our extensive database and from the surrounding communities, to your specific study needs and qualifications. Experienced on-call recruitment team utilized for nights and weekends outside of normal business hours, so a call or inquiry will never be missed.
- Dedicated, on site recruitment center
- Bilingual recruitment team
- Recruitment Rate of 94%
- Constant contact with database of patients via phone, text, email and social media
MOORE Clinical Research consistently delivers positive results over a variety of indications.
ACNE VULGARIS STUDY
Enrollment Goal: 96
Actual Enrollment: 96
Enrollment Rate: 100%
Retention Rate: 93%
Enrollment Timeline: 3 weeks
Actual Enrollment: 96
Enrollment Rate: 100%
Retention Rate: 93%
Enrollment Timeline: 3 weeks
ACNE VULGARIS STUDY
(single site, 3 locations)
Enrollment Goal: 570
Actual Enrollment: 574
Enrollment Rate: 101%
Retention Rate: 90%
Enrollment Timeline: 12 weeks
Enrollment Goal: 570
Actual Enrollment: 574
Enrollment Rate: 101%
Retention Rate: 90%
Enrollment Timeline: 12 weeks
ACTINIC KERATOSIS STUDY
Enrollment Goal: 20
Actual Enrollment: 31
Enrollment Rate: 155%
Retention Rate: 97%
Enrollment Timeline: 12 weeks
Actual Enrollment: 31
Enrollment Rate: 155%
Retention Rate: 97%
Enrollment Timeline: 12 weeks
GLUCOSE MONITOR DEVICE STUDY
Enrollment Goal: 207
Actual Enrollment: 207
Enrollment Rate: 100%
Retention Rate: 100%
Enrollment Timeline: 12 weeks
Actual Enrollment: 207
Enrollment Rate: 100%
Retention Rate: 100%
Enrollment Timeline: 12 weeks
TINEA PEDIS STUDY
Enrollment Goal: 25
Actual Enrollment: 31
Enrollment Rate: 124%
Retention Rate: 97%
Enrollment Timeline: 10 weeks
Actual Enrollment: 31
Enrollment Rate: 124%
Retention Rate: 97%
Enrollment Timeline: 10 weeks
PLAQUE PSORIASIS STUDY
(Pilot study/Rescue site)
Enrollment Goal: 3
Actual Enrollment: 9
Enrollment Rate: 300%
Retention Rate: 100%
Enrollment Timeline: 2 weeks
Enrollment Goal: 3
Actual Enrollment: 9
Enrollment Rate: 300%
Retention Rate: 100%
Enrollment Timeline: 2 weeks
For more information on partnering with MOORE Clinical Research, please contact:
